Market Place
Sourcing Support
ReiThera Appoints Stefano Colloca CEO
07 Jun 2024 //
CONTRACT PHARMA
ReiThera Srl, The Ragon Institute and IAVI Announce Collaboration
22 Jan 2024 //
GLOBENEWSWIRE
ReiThera Expands Viral Vector Production Capabilities Opening New Mfg Facility
14 Nov 2022 //
BIOPHARMINTERNATIONAL
ReiThera Expands Large-scale Viral Vector Production Capabilities
08 Nov 2022 //
CONTRACTPHARMA
ReiThera expands large-scale viral vector production capabilities
03 Nov 2022 //
PRNEWSWIRE
Terumo Pharmaceutical Solutions expanding CDMO reach outside Japan; EUROAPI
03 Nov 2022 //
ENDPTS
ReiThera and Exothera to Make Vaccines for Low- and Middle-Income Countries
13 Apr 2022 //
CONTRACTPHARMA
ReiThera reports positive data from phase 2 COVITAR trial of GRAd-COV2
13 Jul 2021 //
PHARMABIZ
ReiThera reports positive data from phase 2 COVITAR trial of GRAd-COV2
13 Jul 2021 //
PHARMABIZ
ReiThera reports positive data from phase 2 COVITAR trial of GRAd-COV2
12 Jul 2021 //
PHARMABIZ
ReiThera Announces Preliminary Phase 2 Data from its COVID-19 Vaccine Candidate
12 Jul 2021 //
PRNEWSWIRE
Italian COVID-19 vaccine shows strong immune response in mid-stage trial
12 Jul 2021 //
REUTERS
Italy to invest in biotech ReiThera to support COVID-19 vaccine development
05 Jan 2021 //
REUTERS
REITHERA ANNOUNCES ITS GRAD-COV2 COVID-19 VACCINE CANDIDATE IS WELL TOLERATED
24 Nov 2020 //
PRESS RELEASE
EU in early talks with Italy`s ReiThera over potential vaccine supply deal
21 Sep 2020 //
REUTER
ReiThera`s COVID-19 Vaccine Candidate Enters Phase 1 Clinical Study
24 Aug 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.